Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie B Gordon

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nature|January 7, 2021
In vivo base editing rescues Hutchinson-Gilford progeria syndrome in miceLuke W Koblan, Michael R Erdos, Christopher Wilson, et al.
Circulation|July 13, 2016
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeLeslie B Gordon, Monica E Kleinman, Joe Massaro, et al.
Frontiers in Cardiovascular Medicine|May 10, 2024
Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndromeLeslie B Gordon, Sammy Basso, Justine Maestranzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndromeLeslie B Gordon, Monica E Kleinman, David T Miller, et al.
The New England Journal of Medicine|February 8, 2008
Phenotype and course of Hutchinson-Gilford progeria syndromeMelissa A Merideth, Leslie B Gordon, Sarah Clauss, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nature|January 7, 2021
In vivo base editing rescues Hutchinson-Gilford progeria syndrome in miceLuke W Koblan, Michael R Erdos, Christopher Wilson, et al.
Circulation|July 13, 2016
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeLeslie B Gordon, Monica E Kleinman, Joe Massaro, et al.
Frontiers in Cardiovascular Medicine|May 10, 2024
Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndromeLeslie B Gordon, Sammy Basso, Justine Maestranzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndromeLeslie B Gordon, Monica E Kleinman, David T Miller, et al.
The New England Journal of Medicine|February 8, 2008
Phenotype and course of Hutchinson-Gilford progeria syndromeMelissa A Merideth, Leslie B Gordon, Sarah Clauss, et al.
Pageof 6